Compare Hims and Hers Health Inc (HIMS) vs State Street Technology Select Sector SPDR ETF (XLK) Price & Performance

Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.

The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.

XLK trades at $175.71 with minimal daily movement (+0.07%), showing technical bearish signals while maintaining strong year-to-date performance of 33%. The ETF's technical indicators show selling pressure with bearish moving averages, though oscillators remain neutral. Recent news highlights XLK as the top-performing sector SPDR in 2026, driven by technology sector strength and institutional inflows.

Outlook remains positive given technology sector momentum and strong earnings expectations, though concentration risk and technical weakness warrant monitoring. The ETF benefits from sector leadership but faces headwinds from potential Fed policy shifts and market volatility. Current levels near pivot point resistance at $176 suggest near-term consolidation.